| Phase | | A drug requires several trials during the process of being approved. Generally Phase I is designed to test if the drug is safe, Phase II if it is efficacious in a small sample size and Phase III if it is efficacious in a large sample size. |
| Placebo | | An inert substance given as a medicine during clinical trials for its suggestive effect. Recipients are unaware of whether they have been given the placebo or drug being trialled.
|
| Platform | | A collection of technologies that speeds up the process of drug research.
|
| Priority Date | | The date on which a provisional application for a patent was first filed. |
